The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied

The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied

Identification of the NSCLC subtype at an early stage is still quite sophisticated. Metabolomics analysis of tissue and plasma of NSCLC patients may indicate new, and yet unknown, metabolic pathways active in the NSCLC. Our research characterized the metabolomics profile of tissue and plasma of pati...

Full description

Bibliographic Details
Main Authors: Tomasz Kowalczyk, Joanna Kisluk, Karolina Pietrowska, Joanna Godzien, Miroslaw Kozlowski, Joanna Reszeć, Ewa Sierko, Wojciech Naumnik, Robert Mróz, Marcin Moniuszko, Adam Kretowski, Jacek Niklinski, Michal Ciborowski
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
non-small-cell lung cancer
metabolomics
early stage
advanced stage
Online Access:https://www.mdpi.com/2072-6694/13/13/3314

Internet

https://www.mdpi.com/2072-6694/13/13/3314

Similar Items